Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)-Reference-Cited by-同舟云学术

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)

Published:2023-04-12 Issue:7 Volume:58 Page:835-838
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gomez-Arteaga Alexandra^ORCID,Orfali Nina^ORCID,Pasciolla Michelle,Baptiste Ayanna,Guindine Inna,Hsu Jingmei,Lin Jonathan,Mayer Sebastian A.,Phillips Adrienne A.,Shore Tsiporah B.^ORCID,Simonson Paul D.^ORCID,DiCarlo Edward,Yoon Sung,Muthukumar Thangamani,van Besien Koen

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-01981-x.pdf

Reference12 articles.

1. Aydin M, Dovern E, Leeflang MMG, de la Fuente J, Kassim AA, Biemond BJ, et al. Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis. Transplant Cell Ther. 2021;27:e1001–4. https://doi.org/10.1016/j.jtct.2021.09.009.

2. Bolaños-Meade J, Cooke KR, Gamper CJ, Ali SA, Ambinder RF, Borrello IM, et al. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial. Lancet Haematol. 2019;6:e183–e193. https://doi.org/10.1016/S2352-3026(19)30031-6.

3. de la Fuente J, Dhedin N, Koyama T, Bernaudin F, Kuentz M, Karnik L, et al. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative. Biol Blood Marrow Transplant. 2019;25:1197–209. https://doi.org/10.1016/j.bbmt.2018.11.027.

4. Patel C, Pasciolla M, Abramova R, Salerno D, Arteaga AG, Shore TB, et al. Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplant Cell Therap. 2022. https://doi.org/10.1016/j.jtct.2022.10.023.

5. Stenger EO, Shenoy S, Krishnamurti L. How I treat sickle cell disease with hematopoietic cell transplantation. Blood. 2019;134:2249–60. https://doi.org/10.1182/blood.2019000821.